从传统到人工智能驱动的方法:在炎症性肠道疾病中彻底改变个性化和精确营养
Simone Baldi1, Dilara Sarikaya1, Sofia Lotti1
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Clinical nutrition ESPEN
|May 9, 2025
概括
饮食干预和人工智能为管理炎症性肠病 (IBD) 提供了新的希望. 了解肠道微生物群的理解
科学领域:
- 胃肠道学和免疫学
- 营养科学 营养科学
- 计算生物学 计算生物学
背景情况:
- 炎症性肠病 (IBD),包括性结肠炎和克罗恩病,是一种由遗传学,环境和免疫失调影响的慢性疾病.
- 肠道微生物群失调,以改变细菌组成和减少有益微生物为特征,是IBD的标志.
- 饮食是影响IBD病原和进展的关键环境因素.
研究的目的:
- 审查有关IBD患者饮食干预措施的现有证据.
- 探索人工智能 (AI) 在开发IBD个性化营养策略中的作用.
- 要突出基因,肠道微生物群和IBD中的营养之间的相互作用.
主要方法:
- 对IBD,肠道微生物群和营养研究的综合文献综述.
- 对"omics"数据 (基因组学,转录组学,代谢组学) 的分析,以了解分子相互作用.
- 探索人工智能应用在整合复杂的数据集以实现个性化的方法.
主要成果:
- 在IBD中的失生症涉及增加的促炎细菌和减少的SCFA产生微生物.
- 饮食显著影响肠道微生物群的组成和IBD活动.
- "奥米克"技术揭示了复杂的基因-微生物群-营养相互作用.
- 人工智能有助于数据集成,用于IBD的精密营养.
结论:
- 饮食修改对于管理IBD至关重要.
- 人工智能在量身定制饮食干预措施以适应个人IBD患者方面具有重大潜力.
- 将"omics"数据与人工智能集成,可以推进IBD的精准医学.
关键词:
人工智能的人工智能是人工智能.我们的肠道微生物群.IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD精准营养是一种精准的营养.更多相关视频
07:10Author Spotlight: Development and Application of a Canine IBD Gut-on-a-Chip Model for 3D Intestinal Morphogenesis Studies
Published on: February 9, 2024
3.0K
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.0K
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
259
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
259
01:29Inflammatory Bowel Disease IV: Pharmacological Management
82
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
82
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
99
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
99
01:21Inflammatory Bowel Disease V: Surgical Management
69
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
69
01:30Inflammatory Bowel Disease II: Crohn's Disease
134
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
134